Pipeline
The Science
About us
Investors
Investor Overview
Press Releases
ASX Announcements
Events & Presentations
Corporate Governance
Financial Information
Analyst Coverage
Contact Us
Hit enter to search or ESC to close
XBRL 30 June 2019 filed with the SEC
September 2, 2019
August 16, 2022
Alterity Therapeutics
XBRL 30 June 2019
filed with the SEC
Post navigation
Previous Post
Quarterly Cash Flow Report
Next Post
Alterity Therapeutics to Present at the Janney Healthcare Conference in New York
Related Posts
Appendix 4C – Q2 FY23 Quarterly Cash Flow Report
January 31, 2023
May 23, 2023